A Acetate, Paroxetine CEP of the European Pharmacopoeia monograph is often referred to as a Acetate, Paroxetine Certificate of Suitability (COS). The purpose of a Acetate, Paroxetine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Acetate, Paroxetine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Acetate, Paroxetine to their clients by showing that a Acetate, Paroxetine CEP has been issued for it. The manufacturer submits a Acetate, Paroxetine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Acetate, Paroxetine CEP holder for the record. Additionally, the data presented in the Acetate, Paroxetine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Acetate, Paroxetine DMF.
A Acetate, Paroxetine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Acetate, Paroxetine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Acetate, Paroxetine suppliers with CEP (COS) on PharmaCompass.